Researchers advance understanding of Parkinson's disease
Researchers have for the first time identified critical targets in the molecular signature of Parkinson's disease across different stages of the disease's progression.
Apr 10, 2024
0
2
Researchers have for the first time identified critical targets in the molecular signature of Parkinson's disease across different stages of the disease's progression.
Apr 10, 2024
0
2
The Wistar Institute's associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living ...
Apr 10, 2024
0
5
The degree of severity to which someone experiences COVID-19 has a lot to do with the body's immune response to the SARS-CoV-2 virus and the infection it causes. Our immune system tailors antibodies to fight infections, so ...
Feb 21, 2024
0
62
Bacterial vaginosis is a common condition in which the natural microbiome of the vagina falls out of balance, sometimes leading to complications in sexual and reproductive health. But exactly how these bacterial populations ...
Nov 29, 2023
0
8
Finding cancer quickly is key in securing the best possible outcome for the patient.
Jun 5, 2023
0
21
A new HIV vaccine from Scripps Research has shown a significantly improved ability to neutralize the virus in preclinical tests, and it will soon be studied in healthy people who volunteer to participate in clinical trials.
Apr 20, 2023
0
46
Early diagnosis and treatment of Alzheimer's disease requires reliable and cost-effective screening methods. Researchers at Karolinska Institutet in Sweden have now discovered that a type of sugar molecule in blood is associated ...
Apr 12, 2023
0
45
Alterations in the biochemical makeup of bulk plasma IgG, or Fc glycosylation, can predict COVID-19 disease severity and vaccine antibody response, according to a recent study by researchers at RUSH University and Northwestern. ...
Feb 10, 2023
0
103
Antibodies produced against the commonly used antibiotic, gentamicin, appear to increase the risk of type 1 diabetes in children already genetically at risk, scientists say.
Dec 8, 2022
0
278
A cytokine named TRAIL binds to TRAIL receptors and kills cancer cells, but not normal cells. Various anticancer drugs targeting TRAIL receptors have been developed and gained great attention as a promising cancer therapeutics, ...
Aug 15, 2022
0
8